6.12
price up icon5.34%   0.31
 
loading
Silo Pharma Inc stock is traded at $6.12, with a volume of 98,679. It is up +5.34% in the last 24 hours and up +5.24% over the past month. SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's portfolio includes programs such as SPC-15 for PTSD, SP-26 for fibromyalgia and chronic pain, and preclinical assets targeting Alzheimer's disease and multiple sclerosis. The company's product pipelines include: SPC-14, SPC-15, SP-26, and SPU-16. The company operates as a single operating segment as a clinical-stage biopharmaceutical company focused on developing new generation therapies for unmet medical need.
See More
Previous Close:
$5.81
Open:
$5.81
24h Volume:
98,679
Relative Volume:
0.38
Market Cap:
$6.64M
Revenue:
$72,100
Net Income/Loss:
$-4.84M
P/E Ratio:
-0.8207
EPS:
-7.4566
Net Cash Flow:
$-3.84M
1W Performance:
-4.97%
1M Performance:
+5.24%
6M Performance:
+6.00%
1Y Performance:
-31.13%
1-Day Range:
Value
$5.6801
$6.50
1-Week Range:
Value
$5.6801
$6.75
52-Week Range:
Value
$3.315
$15.15

Silo Pharma Inc Stock (SILO) Company Profile

Name
Name
Silo Pharma Inc
Name
Phone
(718) 400-9031
Name
Address
677 N. WASHINGTON BLVD, SARASOTA
Name
Employee
3
Name
Twitter
Name
Next Earnings Date
2026-08-12
Name
Latest SEC Filings
Name
SILO's Discussions on Twitter

Compare SILO vs MOBBW, SHMD, GOODO, PSNYW, DWLD

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
SILO icon
SILO
SILO PHARMA INC
1.71 17.96M 0 0 0 0.00
MOBBW icon
MOBBW
Mobilicom Limited Warrants
2.38 3.16B 0 0 0 0.00
SHMD icon
SHMD
Schmid Group N V
6.54 425.01M 52.15M -21.46M 0 -0.4675
GOODO icon
GOODO
Gladstone Commercial Corporation
20.26 372.90M 0 0 0 0.00
PSNYW icon
PSNYW
Polestar Automotive Holding Uk
2.909 269.09M 2.07B -1.42B -1.37B -0.6765
DWLD icon
DWLD
Davis Select Worldwide ETF
46.61 0 0 0 0 0.00

Silo Pharma Inc Stock (SILO) Latest News

pulisher
Jun 18, 2026

Silo Pharma regains compliance with Nasdaq min bid price requirement - TipRanks

Jun 18, 2026
pulisher
Jun 18, 2026

Silo Pharma Regains Nasdaq Compliance and Advances PTSD Drug SPC-15 Toward Clinical Trials - Minichart

Jun 18, 2026
pulisher
Jun 18, 2026

Silo Pharma Regains Nasdaq Compliance, Stabilizing Listing Status - TipRanks

Jun 18, 2026
pulisher
Jun 18, 2026

Silo Pharma regains Nasdaq minimum bid price compliance, ticker SILO - TradingView

Jun 18, 2026
pulisher
Jun 18, 2026

Silo Pharma (SILO) restores Nasdaq minimum bid price compliance status - Stock Titan

Jun 18, 2026
pulisher
Jun 18, 2026

Silo Pharma (SILO) to vote on director slate, auditor and stock increase at Aug 14 meeting - Stock Titan

Jun 18, 2026
pulisher
Jun 18, 2026

Silo Pharma Says it Regained Compliance With Nasdaq's Minimum Bid Price Requirement - marketscreener.com

Jun 18, 2026
pulisher
Jun 18, 2026

Silo Pharma Regains Compliance With Nasdaq Minimum Bid Price Requirement - TradingView

Jun 18, 2026
pulisher
Jun 18, 2026

Silo Pharma clears Nasdaq’s bid-price test; stock stays listed - Stock Titan

Jun 18, 2026
pulisher
Jun 17, 2026

Silo Pharma Inc (SILO) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

Jun 17, 2026
pulisher
Jun 17, 2026

Silo Pharma Inc (SILO) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey

Jun 17, 2026
pulisher
Jun 17, 2026

Silo Pharma Inc (SILO) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey

Jun 17, 2026
pulisher
Jun 17, 2026

Silo Pharma Inc (SILO) Financial Health: Profitability & Balance Sheet Analysis - TradingKey

Jun 17, 2026
pulisher
Jun 17, 2026

Silo Pharma Inc (SILO) Institutional Confidence - TradingKey

Jun 17, 2026
pulisher
Jun 17, 2026

Silo Pharma Inc (SILO) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey

Jun 17, 2026
pulisher
Jun 16, 2026

Silo Pharma Inc (SILO) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey

Jun 16, 2026
pulisher
Jun 11, 2026

SILO PHARMA INC (SILO) Stock Chart - ChartMill

Jun 11, 2026
pulisher
Jun 11, 2026

SILO Q4 2023 Earnings: EPS Misses Estimates; Pre-Revenue Biotech Faces Cash Burn ConcernsEarnings Outlook Update - newsline.com

Jun 11, 2026
pulisher
Jun 09, 2026

SILO Q4 2023 Earnings: EPS Misses Estimates as Company Advances PipelineDividend Cut Risk - newsline.com

Jun 09, 2026
pulisher
Jun 08, 2026

Why Did SILO Stock Soar 85% Today? - Stocktwits

Jun 08, 2026
pulisher
Jun 04, 2026

Silo Pharma Implements Reverse Stock Split and Restructures Capital - The Globe and Mail

Jun 04, 2026
pulisher
Jun 04, 2026

Silo Pharma Shares Drop Following Implementation of 1-for-15 Reverse Stock Split - Moomoo

Jun 04, 2026
pulisher
Jun 03, 2026

Silo Pharma (SILO) completes 1-for-15 reverse stock split and cuts authorized shares - Stock Titan

Jun 03, 2026
pulisher
Jun 02, 2026

Silo Pharma Announces 1-for-15 Reverse Stock Split - The Globe and Mail

Jun 02, 2026
pulisher
Jun 01, 2026

Silo Pharma announces 1-for-15 reverse stock split effective June 2 - Investing.com UK

Jun 01, 2026
pulisher
Jun 01, 2026

Silo Pharma announces 1-for-15 reverse stock split effective June 2 By Investing.com - Investing.com South Africa

Jun 01, 2026
pulisher
Jun 01, 2026

Silo Pharma to implement 1-for-15 reverse stock split, issued shares fall to ~1.084M - TradingView

Jun 01, 2026
pulisher
Jun 01, 2026

Reverse split shrinks Silo Pharma (NASDAQ: SILO) share count and authorization - Stock Titan

Jun 01, 2026
pulisher
May 28, 2026

SILO Q4 2023 Earnings: EPS Misses Estimates as Development-Stage Biotech Maintains FocusWeak Earnings Momentum - The Legal Advocate

May 28, 2026
pulisher
May 28, 2026

Silo Pharma (SILO) Holds Near Support as Biotech Stock Edges HigherDealer Delta - newsline.com

May 28, 2026
pulisher
May 27, 2026

Silo Pharma Inc. (SILO) Holds Above $0.40 Support After Modest GainsShort Setup Alerts - newsline.com

May 27, 2026
pulisher
May 26, 2026

Silo Pharma (SILO) Surges 5% as Small-Cap Biotech Recovers From Recent LowsSupply Zone - newsline.com

May 26, 2026
pulisher
May 25, 2026

Silo Pharma Inc. (SILO) Rallies 3.99% as Biotech Sentiment Improves — Key Levels in FocusDebt Free Companies - The Legal Advocate

May 25, 2026
pulisher
May 22, 2026

Silo Pharma Inc. (SILO) Q4 2023 Earnings: Widening Losses as Pre-Revenue Biotech Focuses on Pipeline ProgressProfit Margin Analysis - Newser

May 22, 2026
pulisher
May 22, 2026

SILO Q4 2023 Earnings: Biotech Misses EPS Estimates as Pre‑Revenue Phase ContinuesCrowd Stock Picks - Newser

May 22, 2026
pulisher
May 21, 2026

Silo Pharma Inc. (SILO) Edges Higher as Shares Test Key ResistanceAggressive Growth Picks - Newser

May 21, 2026
pulisher
May 21, 2026

Silo Pharma (SILO) Q4 2023 Results Disappoint: What Investors Should KnowRevenue Miss Report - The Legal Advocate

May 21, 2026
pulisher
May 20, 2026

Silo Pharma (SILO) Q4 2023 Earnings: Miss Sparks ConcernTrending Entry Points - Newser

May 20, 2026
pulisher
May 19, 2026

Silo Pharma (SILO) Stock Analysis: Falls -3.79%, Watching $0.35 2026-05-19NHNL Ratio - The Legal Advocate

May 19, 2026
pulisher
May 18, 2026

Silo Pharma (SILO) Q4 2023 Results Miss Estimates — EPS $-0.36 vs $-0.20Special Dividend Alert - newsline.com

May 18, 2026
pulisher
May 14, 2026

Silo Pharma, Inc. (SILO) Q1 2026 10-Q: Financials, Crypto Asset Holdings, and Business Developments - Minichart

May 14, 2026
pulisher
May 14, 2026

Silo Pharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com

May 14, 2026
pulisher
May 13, 2026

Silo Pharma (NASDAQ: SILO) Q1 loss widens as R&D and crypto costs rise - Stock Titan

May 13, 2026
pulisher
May 07, 2026

Silo Pharma Launches Ibogaine-Based TBI Therapeutics Initiative - citybuzz -

May 07, 2026
pulisher
May 07, 2026

Silo Pharma files patent for ibogaine-based TBI treatment By Investing.com - Investing.com Australia

May 07, 2026
pulisher
May 07, 2026

Silo Pharma files patent for ibogaine-based TBI treatment - Investing.com

May 07, 2026
pulisher
May 07, 2026

With no FDA-approved TBI drugs, Silo pursues ibogaine therapy - Stock Titan

May 07, 2026
pulisher
May 07, 2026

Silo Pharma Files Provisional Patent for Ibogaine-Based Therapeutic Targeting Traumatic Brain Injury - ChartMill

May 07, 2026
pulisher
May 05, 2026

Silo Pharma rallies after securing key patent allowance - MSN

May 05, 2026
pulisher
May 04, 2026

SILO Stock Price, Quote & Chart | SILO PHARMA INC (NASDAQ:SILO) - ChartMill

May 04, 2026

Silo Pharma Inc Stock (SILO) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$31.43
price up icon 0.74%
$90.89
price down icon 1.44%
$52.96
price down icon 1.38%
$63.96
price up icon 3.50%
ONC ONC
$270.15
price up icon 2.84%
$162.99
price up icon 3.31%
Cap:     |  Volume (24h):